iTBS Can Increase Frontal Dopamine Release in PET Dopamine Imaging.
- Conditions
- Schizophrenia
- Interventions
- Device: Theta burst stimulation
- Registration Number
- NCT05448430
- Lead Sponsor
- Central South University
- Brief Summary
Aim: 1. To confirm that patients with predominant negative symptoms in schizophrenia have deficits in frontal cortical dopamine release when compared with healthy control and patients with positive symptoms.
2. Our previous study found patients with negative symptoms have more possibilities to have disorders in glucose metabolism, we wonder whether dopamine release, negative symptoms or glucose metabolism can be improved by iTBS.
Study design: Case control study.
- Detailed Description
Eligibility Criteria: Predominant negative symptoms for Positive and Negative Syndrome Scale factor score for negative symptoms of 24 or more, and score of 4 or more on at least two of three core negative PANSS items, PANSS for positive symptoms of 19 or less, HAMD depression scale of 16 or less. Predominant positive symptoms for PANSS for positive symptoms of 20 or more. Healthy control will be recruited matching the age and sex of patient groups, Outcome Measures: Oral glucose tolerance test (OGTT), PET dopamine imaging.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 50
Not provided
- drug or alcohol addiction
- diagnosed with other major mental disorders according to ICD-10 or DSM-V
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description predominant negative symptoms Theta burst stimulation iTBS for predominant negative symptoms
- Primary Outcome Measures
Name Time Method PET dopamine imaging and OGTT immediate PET dopamine imaging and OGTT after iTBS
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Central South University
🇨🇳Changsha, Hunan, China